Andre Hermans PhD

Andre Hermans is a Director in the Analytical Sciences Division at Merck and Co. in Rahway, NJ. He received his Ph.D. from the University of North Carolina in Chapel Hill in Analytical Chemistry before joining Merck in 2007. During his time at Merck, Andre supported analytical method development and process development in the small molecule solid oral dosage area. In this function, he co-authored several IND and NDA applications mainly for formulations containing amorphous solid dispersions. Additionally, he is co-leading Merck’s efforts around in-vivo predictive technologies, dissolution innovations, and clinically relevant specifications. Andre is a member of the IQ dissolution and ICH Q3D workgroups, and a member of the USP expert panel for “New Advancements in Performance Testing”. He is the author of several publications in the field of dissolution testing and clinical relevance.

Andre is an experienced and engaged people manager and mentor and has lead cross-functional teams and directly supervised groups of more than 20 scientists of different levels. He is skilled and experienced in both GMP and non-GMP aspects of drug development, technology transfers, and working with internal and external partners.